-+ 0.00%
-+ 0.00%
-+ 0.00%

LB Pharmaceuticals shareholders elect Class I directors at annual meeting

PUBT·06/09/2026 20:06:24
Listen to the news
LB Pharmaceuticals shareholders elect Class I directors at annual meeting
  • LB Pharmaceuticals held its annual shareholder meeting on June 3, 2026.
  • Shareholders backed the selection of three Class I directors for new three-year terms running to the 2029 annual meeting.
  • Investors ratified BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LB Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-263724), on June 09, 2026, and is solely responsible for the information contained therein.